A citizen-led study on medicine prices and quality has delivered a clear warning for India's healthcare system: the real ...

This approval allows Bionpharma to commercialize the product in the United States, expanding patient access to a more ...

The drugs can save you thousands, but are they as effective? Experts reveal the difference in quality, regulatory challenges, ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Explore why Health Care may mean-revert in 2026. Compare XLV vs BME yields, valuation and NAV discount, plus key risks.

In the regulated pharmaceutical sector, maintaining awareness and connectivity is vital. Industry professionals attend ...

Antsy lobbyists and lawyers, a buzzy press corps and the onslaught of news stories about the fate of President Trump‘s tariffs could lead one to believe it’s the Supreme Court’s opinion season climax ...

Merck’s MRK stock has risen 32.3% in the past three months. The stock has also been trading above its 50-day and 200-day ...

AbbVie’s neuroscience portfolio is also contributing to top-line growth. Sales of its neuroscience drugs increased 20.3% to ...

A new underground industry has emerged where people are buying raw compounds for Ozempic, Botox, filler and skin-tightening treatments directly from Chinese suppliers — and injecting them at ...

In an interview with Sky News during last autumn's Conservative conference, Robert Jenrick appeared to leave the door open to ...

Retirees counting on stable Medicare costs in 2026 are in for some unpleasant surprises, as several rule changes will ...